trial · primary record
Liothyronine Sodium (T3+0.9% sodium chloride) modified formulation specifically for airway instillation.
ARDS, Human
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 19 |
| Primary completion | 2026-10-31 |
| Primary endpoint | Oxygenation: Oxygenation Index (OI), and/or Oxygenation Saturation Index (OSI). |
| Registry ID | NCT04115514 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:54.598Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04115514
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.